Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-038340
Filing Date
2025-08-06
Accepted
2025-08-06 16:15:08
Documents
57
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lxrx-20250630.htm   iXBRL 10-Q 869101
2 EX-31.1 exh311certificationofprinc.htm EX-31.1 9436
3 EX-31.2 exh312certificationofprinc.htm EX-31.2 9241
4 EX-32.1 exh321certificationofprinc.htm EX-32.1 5844
  Complete submission text file 0001628280-25-038340.txt   5152834

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20250630.xsd EX-101.SCH 26004
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lxrx-20250630_cal.xml EX-101.CAL 58533
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lxrx-20250630_def.xml EX-101.DEF 163398
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20250630_lab.xml EX-101.LAB 501227
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20250630_pre.xml EX-101.PRE 335396
60 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20250630_htm.xml XML 650474
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30111 | Film No.: 251189764
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)